Schmitt Industries (SMIT) Competitors $0.02 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SMIT vs. TBIO, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Schmitt Industries stock or one of its competitors? The main competitors of Schmitt Industries include Telesis Bio (TBIO), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Schmitt Industries vs. Its Competitors Telesis Bio Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Which has more risk & volatility, TBIO or SMIT? Telesis Bio has a beta of 2.89, suggesting that its share price is 189% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.4, suggesting that its share price is 140% less volatile than the S&P 500. Do insiders and institutionals hold more shares of TBIO or SMIT? 37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by company insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer TBIO or SMIT? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score. Company Overall Sentiment Telesis Bio Neutral Schmitt Industries Neutral Which has better earnings and valuation, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Schmitt Industries$9.89M0.01-$3.28MN/AN/A Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A SummaryTelesis Bio and Schmitt Industries tied by winning 4 of the 8 factors compared between the two stocks. Get Schmitt Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for SMIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMIT vs. The Competition Export to ExcelMetricSchmitt IndustriesProcess control instruments IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$69K$19.28B$7.57B$9.72BDividend YieldN/A0.61%4.57%4.12%P/E RatioN/A18.6325.0324.70Price / Sales0.016.8199.46101.80Price / CashN/A22.2627.2928.01Price / BookN/A5.064.325.76Net Income-$3.28M$495.21M$795.69M$267.05M7 Day PerformanceN/A-0.04%0.82%5.08%1 Month PerformanceN/A-1.86%0.63%0.61%1 Year PerformanceN/A16.34%30.61%22.83% Schmitt Industries Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMITSchmitt IndustriesN/A$0.02flatN/AN/A$69K$9.89M0.00160Gap DownTBIOTelesis BioN/A$0.02flatN/A-99.4%$40K$225.09M0.00200SPECSpectaireN/A$0.00flatN/AN/A$6KN/A0.008THMOThermoGenesisN/A$0.00+∞N/AN/A$1K$9.61M0.0040Gap UpHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.11-5.9%N/A-42.2%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03+1.8%N/A+135.4%$0.00$41.52M0.001Positive NewsQSIAWQuantum-SiN/A$0.54-7.7%N/A+220.7%$0.00$3.44M0.00150Positive NewsGap DownSMAPWSportsMap Tech AcquisitionN/A$0.03-30.3%N/A+51.2%$0.00N/A0.00N/AGap DownTTTrane Technologies3.9627 of 5 stars$471.64-0.2%$441.40-6.4%+29.3%$105.38B$19.84B40.2845,000News CoveragePositive NewsAnalyst ForecastHigh Trading VolumeKEYSKeysight Technologies4.3575 of 5 stars$167.00+0.2%$187.50+12.3%+34.2%$28.67B$4.98B39.2015,500News CoveragePositive News Related Companies and Tools Related Companies Telesis Bio Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMIT) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schmitt Industries, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schmitt Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
